Title : Pathogenetic aspects of responsiveness to ondansetron (5-hydroxytryptamine type 3 receptor antagonist) in patients with primary fibromyalgia syndrome--a preliminary study.

Pub. Date : 1996 Aug

PMID : 8856622






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Pathogenetic aspects of responsiveness to ondansetron (5-hydroxytryptamine type 3 receptor antagonist) in patients with primary fibromyalgia syndrome--a preliminary study. Ondansetron 5-hydroxytryptamine receptor 3A Homo sapiens
2 OBJECTIVE: To study the efficacy of 5-hydroxytryptamine type 3 receptor (5-HT-3R) antagonist (ondansetron) vs paracetamol in primary fibromyalgia (FM) syndrome. Ondansetron 5-hydroxytryptamine receptor 3A Homo sapiens
3 OBJECTIVE: To study the efficacy of 5-hydroxytryptamine type 3 receptor (5-HT-3R) antagonist (ondansetron) vs paracetamol in primary fibromyalgia (FM) syndrome. Ondansetron 5-hydroxytryptamine receptor 3A Homo sapiens